Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,352,678
+$11,475,399 QoQ
Shares Held
21,971
+35.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#775
of 4,621 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. LLY ranks #7 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,352,678 | 21,971 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,877,279 | 16,175 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,152,482 | 11,308 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,116,208 | 8,016 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,601,702 | 7,186 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,233,142 | 7,547 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,461,388 | 5,779 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,543,779 | 8,515 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,818,385 | 11,949 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,689,356 | 9,884 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,400,170 | 9,264 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,967,242 | 7,386 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,639,085 | 3,495 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,277,178 | 3,719 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,345,193 | 3,677 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,170,203 | 3,619 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,109,190 | 3,421 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $956,475 | 3,340 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $697,731 | 2,526 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,795,395 | 33,739 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $432,645 | 1,885 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $663,584 | 3,552 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||